STAT News

STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test

Servier reports a surprise setback for a drug being tested for a form of muscular dystrophy that lacks treatment.

By STAT News

1 min read
STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights